Parallax Volatility Advisers’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-50,000
Closed -$233K 1763
2024
Q4
$233K Hold
50,000
﹤0.01% 1638
2024
Q3
$347K Hold
50,000
﹤0.01% 1590
2024
Q2
$390K Buy
+50,000
New +$370K ﹤0.01% 1483
2022
Q1
Sell
-300
Closed -$10K 3056
2021
Q4
$10K Sell
300
-115,700
-100% -$4.65M ﹤0.01% 2855
2021
Q3
$4.76M Sell
116,000
-12,400
-10% -$450K ﹤0.01% 1255
2021
Q2
$4.62M Sell
128,400
-89,500
-41% -$3.3M ﹤0.01% 1269
2021
Q1
$8.51M Buy
217,900
+64,700
+42% +$2.91M 0.01% 1022
2020
Q4
$6.18M Buy
+153,200
New +$7.04M ﹤0.01% 1312

Other funds holding GDRX

Parallax Volatility Advisers's GDRX Position: Q1 2025 in Review

Parallax Volatility Advisers sold out of GoodRx Holdings (GDRX) in Q1 2025, closing a stake of 43,877 shares — an estimated $204K sold.

Parallax Volatility Advisers first reported a position in GDRX in Q4 2020 and held it in 7 quarters. The position peaked at $3.27M in Q2 2021. 170 funds tracked by Wall St. Rank hold GDRX as of Q1 2025.

  • Parallax Volatility Advisers reported no remaining GoodRx Holdings position as of Q1 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 43,877 GoodRx Holdings shares in Q1 2025, an estimated $204K.
  • Parallax Volatility Advisers first reported a position in GoodRx Holdings in Q4 2020 and held it in 7 quarters.
  • Parallax Volatility Advisers's GoodRx Holdings position peaked at $3.27M in Q2 2021.
  • 170 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2025.

Based on Parallax Volatility Advisers's 13F filing for Q1 2025, filed 15 May 2025.